Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of the preoperative modified Glasgow Prognostic Score on disease outcome after radical cystectomy for urothelial carcinoma of the bladder.
Schuettfort VM, Gust K, D'Andrea D, Quhal F, Mostafaei H, Laukhtina E, Mori K, Rink M, Abufaraj M, Karakiewicz PI, Luzzago S, Rouprêt M, Enikeev D, Zimmermann K, Deuker M, Moschini M, Sari Motlagh R, Grossmann NC, Katayama S, Pradere B, Shariat SF. Schuettfort VM, et al. Among authors: sari motlagh r. Minerva Urol Nephrol. 2022 Jun;74(3):302-312. doi: 10.23736/S2724-6051.21.04216-6. Epub 2021 Jun 11. Minerva Urol Nephrol. 2022. PMID: 34114784 Free article.
Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysis.
Mori K, Miura N, Mostafaei H, Quhal F, Sari Motlagh R, Pradere B, Kimura S, Kimura T, Egawa S, Briganti A, Karakiewicz PI, Shariat SF. Mori K, et al. Among authors: sari motlagh r. Prostate Cancer Prostatic Dis. 2020 Dec;23(4):539-548. doi: 10.1038/s41391-020-0222-6. Epub 2020 Mar 9. Prostate Cancer Prostatic Dis. 2020. PMID: 32152435
Prognostic value of testosterone for the castration-resistant prostate cancer patients: a systematic review and meta-analysis.
Miura N, Mori K, Mostafaei H, Quhal F, Sari Motlagh R, Abufaraj M, Pradere B, Aydh A, Laukhtina E, D'Andrea D, Saika T, Shariat SF. Miura N, et al. Among authors: sari motlagh r. Int J Clin Oncol. 2020 Nov;25(11):1881-1891. doi: 10.1007/s10147-020-01747-1. Epub 2020 Jul 17. Int J Clin Oncol. 2020. PMID: 32681382 Free PMC article.
Primary Ta high grade bladder tumors: Determination of the risk of progression.
Quhal F, D'Andrea D, Soria F, Moschini M, Abufaraj M, Rouprêt M, Karakiewicz PI, Yang L, Mostafaei H, Laukhtina E, Mori K, Sari Motlagh R, Rink M, Shariat SF. Quhal F, et al. Among authors: sari motlagh r. Urol Oncol. 2021 Feb;39(2):132.e7-132.e11. doi: 10.1016/j.urolonc.2020.07.017. Epub 2020 Aug 7. Urol Oncol. 2021. PMID: 32773232
Association of De Ritis ratio with oncological outcomes in patients with non-muscle invasive bladder cancer (NMIBC).
Laukhtina E, Mostafaei H, D'Andrea D, Pradere B, Quhal F, Mori K, Miura N, Schuettfort VM, Sari Motlagh R, Aydh A, Abufaraj M, Karakiewicz PI, Enikeev D, Kimura S, Shariat SF. Laukhtina E, et al. Among authors: sari motlagh r. World J Urol. 2021 Jun;39(6):1961-1968. doi: 10.1007/s00345-020-03384-9. Epub 2020 Aug 17. World J Urol. 2021. PMID: 32808107 Free PMC article.
66 results